MarketInOut Stock Screener Log In | Sign Up
 

Biodesix Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 07/24/2026
Biodesix Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization224.51 mln
Float4.69 mln
Earnings Date08/05/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.73
Likely reliable

1-Year Forecast

30.83
Exceptional upside

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

7.84
Extremely leveraged

ROE

-932
Deeply negative

Business Description

Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.

Key Fundamentals

EPS-3.96
ROE-932
RPS11.84
ROIC-38.40
ROA-35.92
EBITDA, mln-18.34
EV / EBITDA-15.65
EV / EBIT-11.98
Revenue, mln96.10
EV / Revenue2.99

Financial Strength

Altman Z-Score-5.27
Piotroski F-Score 5 / 9
Beneish M-Score-2.73
1-Year Target Price30.83
Short Ratio1.29
Short % of Float1.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.96% 96 / 100   
1 Month 17.84% 96 / 100   
2 Months 65.29% 97 / 100   
6 Months 98.2% 98 / 100   
1 Year 159% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us